天工國際(00826.HK)擬分拆附屬天工工具於內地上市
天工國際(00826.HK)公布,為整合資源及擴充強化高速鋼及模具鋼業務,計劃分拆附屬公司天工工具於中國境內一家證券交易所獨立上市,董事會已授權公司及天工工具管理層啟動擬分拆事項的前期籌備工作,包括但不限於可行性計劃研究、組織編製上市方案、簽署籌劃過程中涉及的相關協議等上市相關事宜。
天工國際表示,目前持有天工工具82.35%股份,為其控股股東,天工工具已完成股權激勵、引入戰略投資者等相關工作,預期分拆不會導致公司喪失對天工工具的控制權,天工工具仍會為旗下附屬公司, 料不會損害公司獨立上市地位和持續盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.